Skip to main content
. 2014 Jan 4;71(11):2047–2063. doi: 10.1007/s00018-013-1543-6

Table 2.

Percent amino acid composition of yeast PFDs and human disease-associated PrLDs

Gln/Asn Ser Gly Tyr Chargeda Hydrophobicb
Yeast PFDsc
 Ure2 48.3 11.2 5.6 0 11.2 15.7
 Rnq1 43.1 15.4 16.7 5.9 2.4 8.3
 Sup35 45.6 3.5 16.7 17.5 4.4 3.5
 PFD averaged 45.7 10.0 13.0 7.8 6.0 9.2
 Yeast genome 10.0 9.0 5.0 3.4 24.0 28.3
Human PrLDse
 TDP-43 21.8 15.9 26.8 0.7 3.5 15.9
 FUS 21.5 22.8 28.3 12.2 3.8 0.8
 TAF15 27.7 22.4 15.1 15.1 10.6 1.3
 EWSR1 18.9 15.4 9.6 13.6 3.6 4.0
 hnRNPA2B1 12.7 9.6 45.2 10.8 9.5 6.4
 hnRNPA1 12.3 16.0 42.2 8.0 9.7 8.1
 TIA1 31.6 4.2 15.8 9.5 2.1 12.6
 PrLD average 20.9 15.2 26.1 10.0 6.1 7.0
 Human genome 8.3 8.1 6.6 2.8 22.9 26.5
 PrPf 12.8 5.7 9.9 7.8 20.6 19.9

aCharged residues include D, E, K, R

bHydrophobic residues include F, I, L, M, V

cPFDs are as defined in Table 1

dAverage of the Ure2, Sup35, and Rnq1 PFDs

eDisease-associated PrLDs found in RRM-containing proteins, as defined by the Alberti algorithm [21]

fAmino acids 90–230, which constitute the protease-resistant core of prion aggregates